Product information»
Mode of action»
Preclinical results»
Clinical oncological effects»
Frequently asked questions»
References»

Clinical oncological effects

Review - The supportive effects of avemar in clinical care

In summary, let us state that Avemar is not an alternative oncologic agent, nor is it an alternative for oncological treatments, as under no circumstances is Avemar a re-placement for surgery, chemotherapy, radiotherapy, hormone (hormone-antagonistic) therapy, immune therapy, biological therapy or any other anticancer therapy - however, nothing replaces Avemar, either. Avemar works in a different way and has an additive way, often also potentiating their effects (as in estrogen-receptor-positive breast cancer [33].) It is recommended that Avemar be taken continuously and without interruption in strict compliance with the instructions on the packaging until the disease is cured.
» More

»Review
The supportive effects ofavemar in clinical care
Home